Eligibility criteria
Condition
NSCLC
Sex
Females and Males
Age
20 + years
Inclusion criteria
Show details
- Patients who received dacomitinib on another clinical trial in Japan
- Evidence of a personally signed and dated informed consent document
Exclusion criteria
Show details
- Patients who meet one or more study withdrawal criteria on the prior study
- Participation in other studies involving other investigational drug(s) during study
participation